Wilairat P, Phrommintikul A, Chotayaporn T, Wattanasombat S, Hmuenpha R, Kornjirakasemsan S
Chronic Dis Transl Med. 2025; 11(1):57-68.
PMID: 40051818
PMC: 11880128.
DOI: 10.1002/cdt3.154.
Shalaby S, Battistel M, Groff S, Birbin L, Miraglia R, Angeli P
JHEP Rep. 2025; 7(3):101301.
PMID: 40041118
PMC: 11876882.
DOI: 10.1016/j.jhepr.2024.101301.
De Marchis G, Toebak A, Dittrich T, Vlachos D, Wang A, Smith E
Eur Stroke J. 2025; :23969873251323180.
PMID: 40008571
PMC: 11866338.
DOI: 10.1177/23969873251323180.
Abdul Aziz N, Palaniappan S, Kamal Rodin N, Chong G, Jerome T, Aizuddin A
J Clin Med. 2025; 14(3).
PMID: 39941428
PMC: 11818754.
DOI: 10.3390/jcm14030759.
Liporace I, Oliveira G, Alves L, Galassi N, Jeronimo A, Lopes F
Arq Bras Cardiol. 2025; 122(2):e20240147.
PMID: 39936736
PMC: 11818470.
DOI: 10.36660/abc.20240147.
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism.
Svalastoga M, Larsen T, Brekke J, Enden T, Froen H, Garresori H
Front Oncol. 2025; 15:1520725.
PMID: 39931081
PMC: 11807833.
DOI: 10.3389/fonc.2025.1520725.
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label study.
Cosgrave D, McNicholas B, Hanley C, Sheehan J, Calpin P, Kernan M
Intensive Care Med Exp. 2025; 13(1):15.
PMID: 39920521
PMC: 11806160.
DOI: 10.1186/s40635-025-00727-x.
Longitudinal assessment of cerebral infarcts and small vessel disease using magnetic resonance imaging in antiphospholipid syndrome: A single-centre retrospective study.
Tan Y, Doyle A, Kumar J, Somerville P, Faruqi U, Danaee A
EJHaem. 2025; 6(1):e1065.
PMID: 39917355
PMC: 11800375.
DOI: 10.1002/jha2.1065.
Efficacy and safety of anti-Xa direct oral anticoagulants vs. warfarin in patients homozygous for Factor V Leiden and prothrombin G20210A mutations.
Dan O, Pikovsky O, Kerman T, Amar S, Rabinovich A
J Thromb Thrombolysis. 2025; 58(2):188-198.
PMID: 39891866
DOI: 10.1007/s11239-025-03069-3.
Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study.
El-Bardissy A, Elshafei M, Abdelgawad H, Mekkawi R, Eltahir A, Mohammed A
Thromb J. 2025; 23(1):9.
PMID: 39885575
PMC: 11780795.
DOI: 10.1186/s12959-025-00685-0.
The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adults.
Parks A, Slager S, Cizik A, Fang M, Supiano M, Katz P
PLoS One. 2025; 20(1):e0316796.
PMID: 39879194
PMC: 11778767.
DOI: 10.1371/journal.pone.0316796.
Comparison of Direct Oral Anticoagulants for Treatment of Cerebral Venous Thrombosis - A Retrospective Cohort Study.
Phan P, Hong L
Clin Appl Thromb Hemost. 2025; 31:10760296251316869.
PMID: 39877972
PMC: 11775976.
DOI: 10.1177/10760296251316869.
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis.
Mahmoud A, Mostafa M, Abdelhay A, Abou-Ismail M, Chaturvedi S
Res Pract Thromb Haemost. 2025; 9(1):102654.
PMID: 39830971
PMC: 11742298.
DOI: 10.1016/j.rpth.2024.102654.
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis.
Alqeeq B, Abo-Elnour D, Rifai M, Gamboa L, Qattea I, Hamzah M
Thromb J. 2025; 23(1):4.
PMID: 39825435
PMC: 11740442.
DOI: 10.1186/s12959-024-00674-9.
Impact of Antithrombotic Therapy on Thrombotic and Bleeding Complications after Elective Endovascular Repair of Abdominal Aortic Aneurysms.
Kranendonk J, Vermulst A, van der Veen D, Kramers C, Warle M, Reijnen M
Cardiovasc Intervent Radiol. 2025; 48(2):157-166.
PMID: 39821653
PMC: 11790793.
DOI: 10.1007/s00270-024-03946-z.
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials.
Jenab Y, Sadeghipour P, Mohseni-Badalabadi R, Kaviani R, Hosseini K, Pasebani Y
EuroIntervention. 2025; 21(1):82-92.
PMID: 39773831
PMC: 11684328.
DOI: 10.4244/EIJ-D-24-00527.
Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients.
Vichaidit K, Chantrathammachart P, Niparuck P, Puawilai T, Angchaisuksiri P, Boonyawat K
Res Pract Thromb Haemost. 2025; 9(1):102643.
PMID: 39759126
PMC: 11699720.
DOI: 10.1016/j.rpth.2024.102643.
A new strategy for monitoring of direct oral anticoagulants in patients with cyanotic and complex congenital heart disease.
Dirbach F, Goulouti E, Bouchardy J, Ladouceur M, Alberio L, Rutz T
Int J Cardiol Congenit Heart Dis. 2024; 18:100545.
PMID: 39713224
PMC: 11657253.
DOI: 10.1016/j.ijcchd.2024.100545.
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Di Vece D, Valgimigli M, Barnathan E, Connors J, Cools F, Held U
Res Pract Thromb Haemost. 2024; 8(8):102613.
PMID: 39698185
PMC: 11652863.
DOI: 10.1016/j.rpth.2024.102613.
Correlation between thrombocytopenia and adverse outcomes in patients with atrial fibrillation: a systematic review and meta-analysis.
Ding Q, Xu W, Chen Y, Chang S, Zhang J
Front Cardiovasc Med. 2024; 11:1383470.
PMID: 39691493
PMC: 11649656.
DOI: 10.3389/fcvm.2024.1383470.
